Othman Salim Akhtar

Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry

Rachel Cusatis, Carlos Litovich, Zhongyu Feng et al. · Transplantation and Cellular Therapy · 2024 · 61 citations · Full text

Dose reductions in ibrutinib therapy are not associated with inferior outcomes in patients with chronic lymphocytic leukemia (CLL)

Othman Salim Akhtar, Kristopher Attwood, Ian Lund et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 40 citations

Hematological Malignancy, Lymphoid Neoplasia, Dose Reductions +15

Real World Outcomes with Idecabtagene Vicleucel (Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar et al. · Blood · 2023 · 29 citations

Contemporary Trends and Comparative Outcomes With Adjunctive Inferior Vena Cava Filter Placement in Patients Undergoing Catheter-Directed Thrombolysis for Deep Vein Thrombosis in the United States

Othman Salim Akhtar, Vladimir Lakhter, Chad Zack et al. · JACC: Cardiovascular Interventions · 2018 · 23 citations

Pulmonary Embolism, Thrombosis, Catheter-directed Thrombolysis +9

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Yazeed Sawalha, Subir Goyal, Jeffrey M. Switchenko et al. · Blood Advances · 2023 · 23 citations · Full text

Venetoclax Monotherapy, Lymphoid Neoplasia, Disease Relapse +13